Safety and immunogenicity of boosting with a severe acute respiratory syndrome coronavirus 2 omicron variant mRNA vaccine in healthy adults: An open‐label, and single‐arm Phase 1 study.
- Resource Type
- Article
- Source
Clinical & Translational Medicine . Aug2023, Vol. 13 Issue 8, p1-4. 4p.- Subject
- *
SARS-CoV-2
*SARS-CoV-2 Omicron variant
*CORONAVIRUS diseases
*IMMUNE response
*SARS-CoV-2 Delta variant
*COVID-19 - Language
- ISSN
- 2001-1326